PODCAST-19: FiveThirtyEight on the Novel Coronavirus

Why A Vaccine Trial Would Press Pause

09.12.2020 - By FiveThirtyEight, Anna RothschildPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

We discuss the news that AstraZeneca's COVID-19 vaccine trial has been paused because of a severe side effect for one participant, and how temporarily halting a trial can sometimes mean the process is working as intended.

More episodes from PODCAST-19: FiveThirtyEight on the Novel Coronavirus